(0.25%) 5 535.50 points
(0.26%) 39 570 points
(0.25%) 19 978 points
(0.63%) $82.05
(-1.96%) $2.55
(0.33%) $2 347.40
(0.12%) $29.60
(-0.61%) $995.80
(-0.30%) $0.930
(-0.35%) $10.64
(-0.18%) $0.789
(2.07%) $87.50
5.03% $ 4.80
Live Chart Being Loaded With Signals
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health...
Stats | |
---|---|
Объем за сегодня | 108 389 |
Средний объем | 149 783 |
Рыночная капитализация | 1.70B |
EPS | $-0.120 ( Q1 | 2024-03-31 ) |
Дата следующего отчета о доходах | ( $-0.0600 ) 2024-08-27 |
Last Dividend | $0.0722 ( 2019-01-11 ) |
Next Dividend | $0 ( N/A ) |
P/E |
-17.78 (Sector) 49.64 (Industry) 35.32 |
ATR14 | $0.0180 (0.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2018-10-22 | Anderson Mark Monroe | Buy | 100 000 | Stock Option (right to buy) |
2018-10-22 | Anderson Mark Monroe | Buy | 0 | |
2018-08-13 | Smith Scott Clifford | Buy | 100 000 | Stock Option (right to buy) |
2018-08-13 | Smith Scott Clifford | Buy | 0 | |
2018-08-13 | Laffer Arthur B | Buy | 100 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 13 transactions |
Buy: 500 392 | Sell: 1 057 |
Объем Корреляция
Eaton Vance Ohio Корреляция
10 Самые положительные корреляции | |
---|---|
HTZ | 0.916 |
ACHR-WT | 0.905 |
PNST | 0.904 |
CCG | 0.896 |
PPG | 0.89 |
GETY | 0.889 |
RHI | 0.888 |
AZUL | 0.888 |
CPRI | 0.886 |
YCL | 0.883 |
10 Самые отрицательные корреляции | |
---|---|
MRDB | -0.888 |
RRAC | -0.887 |
YCS | -0.883 |
TRIS | -0.873 |
TCOA | -0.871 |
TRTL | -0.87 |
TFPM | -0.868 |
APCA | -0.867 |
USDU | -0.865 |
MAIN | -0.864 |
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Eaton Vance Ohio Корреляция - Валюта/Сырье
Eaton Vance Ohio Финансовые показатели
Annual | 2023 |
Выручка: | $781.43M |
Валовая прибыль: | $175.05M (22.40 %) |
EPS: | $-0.470 |
FY | 2023 |
Выручка: | $781.43M |
Валовая прибыль: | $175.05M (22.40 %) |
EPS: | $-0.470 |
FY | 2022 |
Выручка: | $751.45M |
Валовая прибыль: | $174.07M (23.16 %) |
EPS: | $-0.990 |
FY | 2021 |
Выручка: | $618.03M |
Валовая прибыль: | $151.54M (24.52 %) |
EPS: | $0.650 |
Financial Reports:
No articles found.
Eaton Vance Ohio Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0561 | 2001-01-05 |
Last Dividend | $0.0722 | 2019-01-11 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 221 | -- |
Total Paid Out | $14.33 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.06 | -- |
Div. Sustainability Score | 2.23 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.212 | -- |
Year | Amount | Yield |
---|---|---|
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $1.008 | 24.50% |
2005 | $1.024 | 55.70% |
2006 | $0.704 | 34.50% |
2007 | $0.650 | 153.20% |
2008 | $0.738 | 177.80% |
2009 | $0.814 | 150.70% |
2010 | $0.966 | 61.90% |
2011 | $0.857 | 41.40% |
2012 | $0.832 | 54.40% |
2013 | $0.793 | 45.30% |
2014 | $0.732 | 28.90% |
2015 | $0.732 | 32.70% |
2016 | $0.570 | 25.20% |
2017 | $0.576 | 14.20% |
2018 | $0.495 | 6.05% |
2019 | $0.0722 | 0.71% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
11 Jan 2019 | $0.0722 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
12 Dec 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
10 Oct 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
13 Sep 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
10 Aug 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
11 Jul 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
08 Jun 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
10 May 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
11 Apr 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
09 Mar 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
09 Feb 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
11 Jan 2018 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
08 Dec 2017 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
10 Nov 2017 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
11 Oct 2017 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
08 Sep 2017 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
09 Aug 2017 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
11 Jul 2017 | $0.0451 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
08 Jun 2017 | $0.0509 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
09 May 2017 | $0.0509 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ECC | Dividend Diamond | 2024-07-11 | Monthly | 11 | 14.91% | 9.72 |
BRW | Dividend Diamond | 2024-06-11 | Monthly | 33 | 9.41% | 9.26 |
VVR | Dividend Diamond | 2024-06-18 | Monthly | 27 | 8.85% | 9.19 |
FCT | Dividend Diamond | 2024-06-03 | Monthly | 21 | 8.33% | 9.14 |
PHK | Dividend Diamond | 2024-06-13 | Monthly | 22 | 9.07% | 9.13 |
SBR | Dividend Diamond | 2024-06-17 | Monthly | 38 | 9.57% | 9.10 |
XFLT | Dividend Diamond | 2024-06-17 | Monthly | 8 | 10.49% | 9.09 |
SRV | Dividend Royal | 2024-07-16 | Monthly | 18 | 10.61% | 9.04 |
FAM | Dividend Royal | 2024-06-03 | Monthly | 20 | 8.07% | 8.98 |
RA | Dividend Diamond | 2024-06-11 | Monthly | 9 | 10.10% | 8.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.117 | 1.500 | -2.34 | -3.50 | [0 - 0.5] |
returnOnAssetsTTM | -0.0411 | 1.200 | -1.369 | -1.642 | [0 - 0.3] |
returnOnEquityTTM | -0.0799 | 1.500 | -1.999 | -3.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.865 | 0.800 | 5.68 | 4.54 | [1 - 3] |
quickRatioTTM | 1.634 | 0.800 | 5.10 | 4.08 | [0.8 - 2.5] |
cashRatioTTM | 0.967 | 1.500 | 5.74 | 8.61 | [0.2 - 2] |
debtRatioTTM | 0.284 | -1.500 | 5.26 | -7.90 | [0 - 0.6] |
interestCoverageTTM | -8.44 | 1.000 | -4.24 | -4.24 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0782 | 2.00 | -0.0261 | -0.0521 | [0 - 30] |
freeCashFlowPerShareTTM | -1.274 | 2.00 | -0.637 | -1.274 | [0 - 20] |
debtEquityRatioTTM | 0.567 | -1.500 | 7.73 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.202 | 1.000 | 9.97 | 9.97 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.129 | 1.000 | -4.59 | -4.59 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.0221 | 1.000 | -1.234 | -1.234 | [0.2 - 2] |
assetTurnoverTTM | 0.352 | 0.800 | -0.989 | -0.791 | [0.5 - 2] |
Total Score | 2.23 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -8.72 | 1.000 | -0.982 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0799 | 2.50 | -1.285 | -3.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.274 | 2.00 | -0.425 | -1.274 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0782 | 2.00 | -0.0261 | -0.0521 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.614 | 1.500 | -7.43 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0179 | 1.000 | -2.95 | 0 | [0.1 - 0.5] |
Total Score | -1.804 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Eaton Vance Ohio
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа